Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial - Aix-Marseille Université Access content directly
Journal Articles Cancer Research Year : 2018

Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

Sonja Vliek
  • Function : Author
Agnes Jager
  • Function : Author
Mojca Jonge-Lavrencic
  • Function : Author
Jean-Pierre Lotz
  • Function : Author
Monika Graeser
  • Function : Author
Ulrike Nitz
  • Function : Author
Ingrid A. M. Mandjes
  • Function : Author
Marjo J. Holtkamp
  • Function : Author
Margaret Schot
  • Function : Author
Valesca P. Retel
  • Function : Author
Evelien J. Kuip
  • Function : Author
Machteld N. Wymenga
  • Function : Author
Inge R. Konings
  • Function : Author
Vivianne C. G. Tjan-Heijnen
  • Function : Author
Judith R. Kroep
  • Function : Author
Der Carolien P. Schr
  • Function : Author
Elsken van Der Wall
  • Function : Author
Sabine C. Linn
  • Function : Author
No file

Dates and versions

hal-02143680 , version 1 (29-05-2019)

Identifiers

  • HAL Id : hal-02143680 , version 1

Cite

Sonja Vliek, Agnes Jager, Mojca Jonge-Lavrencic, Jean-Pierre Lotz, Anthony Goncalves, et al.. Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial. Cancer Research, 2018, 78 (4, S). ⟨hal-02143680⟩

Collections

CNRS UNIV-AMU CRCM
59 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More